Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageWe are a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market. We initially incorporated in Costa Rica in 2004 and subsequently reorganized in 2013 under a parent holding company in the British Virgin Islands. Our line of silicone gel-filled breast implants, branded as Motiva Implants, is the centerpiece of our medical technology platform.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Business segments
Q2 2026 · $67.5MThe company’s own SEC segment disclosure.
- Non Us$42.8M63%
- United States$24.7M37%
Establishment Labs Holdings Inc. (ESTA) reported revenue of $68M in Q2 2026 (quarter ended Jun 30, 2026), up 32% from the same quarter a year earlier. That came with a gross margin of 71% and net loss of $12M. For the full year FY2025, revenue was $211M (+27% year on year) and net income −$51M. Its largest region in Q2 2026 was Non Us at $43M, 63% of the disclosed total, well ahead of United States at 37%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.